alexa
ISSN 2155-6113

Journal of AIDS & Clinical Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..

Editorial Board

Recommended Conferences

Submit Manuscript

Journal Impact Factor 1.22* ; 2.7* (5 Year Impact Factor)
Submit manuscript at http://www.editorialmanager.com/acrgroup or send as an e-mail attachment to the Editorial Office at editor.jar@omicsonline.net

About the Journal

H-Factor: 9
Google Scholar h5 index: 14

Index Copernicus Value: 104.14

Acquired Immune Deficiency Syndrome (AIDS) is a disease caused due to HIV virus that affects the human immune system tremendously eventually leading to death. HIV is considered as one of the fatal cause of death in the present times. The global scenario of AIDS is alarming and number of infected patients is regularly increasing. The rapid adaptation and evolution of the virus is another important issue. Hybridization of various subtypes is posing challenge to the global efforts for remedy. Extensive clinical contribution is necessary starting from detection to therapy. Although, therapeutic procedures such as HAART is existing but constant challenge is being faced due to the evolution of the virus.

Journal of AIDS & Clinical Research provides a global open access platform to put forth the research and relevant discussions on this burning issue. This journal considers almost all aspects of research and social issues related to HIV and AIDS encompassing clinical virology, molecular biology and epidemiology, HIV anxiety disorder, virologic failure, multiple comorbidities, HIV dementia scale, tertiary facility in relation to HIV, perceived susceptibility, drug resistance, drug toxicity, clinical research with relation to HIV treatment regime etc. Discussions on clinical aspects that determine the safety and effectiveness of medications, devices, diagnostic products and treatment regimens associated with treatment of HIV and co-infected patients are also welcome in this journal. Essential information on advances in the diagnosis and treatment of HIV infections as well as on the development of therapeutics and experimental vaccines are also welcome for publication. Novel contributions are expected to maintain the quality of the journal and to achieve high impact factor.

This AIDS journal is a scholarly journal maintains high standards of scientific excellence and its editorial board ensures a rapid peer review process with the help of the Editorial Manager System. Manuscripts are accepted for publication only if at least two reviewers agree on the scientific quality of a submitted manuscript.

 

 

Advances in HIV Tests

Many advanced HIV testing methodologies has been developed to reduce the risk of HIV infection. HIV testing helps to improve the health outcomes for the people living with HIV. Window period, ELISA, ELISA dongle, Western blot, Rapid or point-of-care tests, Interpreting antibody tests, Accuracy of HIV testing are the Antibody tests. Some other methods for HIV testing are Antigen tests, Nucleic acid-based tests, Screening, CD4 T-cell count, Oral tests, AIDS denialism and fraudulent testing.

Related Journals of Advances in HIV Tests

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, AIDS, AIDS Research and Human Retroviruses, AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, AIDS and Behavior and International Journal of STD and AIDS, AIDS Journals, AIDS, Journal of acquired immune deficiency syndrome, Advances in HIV Treatment, International HIV journal, AIDS Education and Prevention, International Journal of STD & AIDS, HIV/AIDS - Research and Palliative Care, HIV Medicine, Journal of AIDS and HIV research.

HIV Status

People who infected with the human immunodeficiency virus are called as HIV infected people and they abbreviated as PLWHA (People Living With HIV/AIDS). According to the AIDS epidemic update by UNAIDS in 2007, 33.2 million people are infected with HIV/AIDS and more than 68% of infected HIV individuals are living in Sub-Saharan Africa. According to a UNAIDS report, more than 4 million people were receiving antiretroviral therapy by the end of 2008 and there is an increase of 1 million compared with the end of 2007.

Related Journals of HIV Status

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, AIDS Education and Prevention, AIDS Patient Care and STDs, AIDS Reviews, Current Opinion in HIV and AIDS and Journal of the Association of Nurses in AIDS Care, Journal of the International AIDS Society, Open AIDS Journal, HIV clinical trials journal, Journal of clinical research in HIV AIDS and prevention, Risk Behaviours of HIV/AIDS Journals, HIV/AIDS journals, Journal on HIV, HIV Journals, Journal of AIDS, AIDS and behavior journal, AIDS Patient Care and STDs, AIDS journal.

Advances in HIV Diagnosis

People with acute HIV infection have demonstrated enhanced transmission of HIV in multiple epidemiologic and pathogenic studies. Improved methods of HIV testing could decrease this number, as well as identify those who have recently acquired HIV infection and are at the most critical stage of infectivity. Surveillance is the on-going systematic collection, analysis, interpretation, and reporting of information that leads to action being taken to prevent and control disease.

• Enhanced HIV/AIDS Reporting System (eHARS)

• Electronic Laboratory Reporting (ELR)

• Electronic Medical Records

HIV Incidence Surveillance

Related Journals of Advances in HIV Diagnosis

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, AIDS, Supplement, Current HIV/AIDS Reports, AIDS Reader, AIDS Research and Therapy and Journal of the International AIDS Society, HIV/AIDS - Research and Palliative Care, HIV Medicine, Journal of AIDS and HIV research, AIDS research and treatment, AIDS Care, Antiretroviral Treatment Journals, Journal of the International AIDS Society, Open AIDS Journal, HIV clinical trials journal, Journal of clinical research in HIV AIDS and prevention, Risk Behaviours of HIV/AIDS Journals, HIV/AIDS journals, Journal on HIV, HIV Journals, Journal of AIDS, AIDS and behavior journal.

HIV Vaccines

A vaccine is a biological preparation that protects against the deadly infections or diseases. Vaccines have been developed for smallpox, polio, measles, and yellow fever but not for the HIV. Currently we do not have effective vaccine to protect human immune system from HIV virus. Still scientists are in clinical trials to find out significant vaccines that prevent from HIV infection.

Related Journals of HIV Vaccines

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, Journal of the International Association of Physicians in AIDS Care, African Journal of AIDS Research, AIDS and Public Policy Journal, AIDS Research and Treatment and AIDS clinical care, HIV/AIDS - Research and Palliative Care, HIV Medicine, Journal of AIDS and HIV research, AIDS research and treatment, AIDS Care, Antiretroviral Treatment Journals, Journal of the International AIDS Society, Open AIDS Journal, HIV clinical trials journal, Journal of clinical research in HIV AIDS and prevention, Risk Behaviours of HIV/AIDS Journals, HIV/AIDS journals, Journal on HIV, HIV Journals, Journal of AIDS, AIDS and behavior journal.

Advances in Preventive Transmitted Disease

Accurate immune chromatographic assays to detect HIV, hepatitis C virus (HCV) and syphilis antibodies have made home or supervised self-testing possible along with feasibility and excellent test characteristics for HIV, HCV and syphilis POC tests. Several rapid oral HIV tests are now available for purchase along with combined HIV and syphilis tests using a single finger prick blood sample are evolving. Sexually transmitted infections (STIs) remain a major global public health issue, with million incident bacterial infections each year.

Related Journals of Advances in Preventive Transmitted Disease

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, Sexually Transmitted Diseases, Indian Journal of Sexually Transmitted Diseases, Journal of HIV/AIDS Prevention and Education for Adolescents and Children, Journal of HIV/AIDS and Social Services and Journal of Neuro-AIDS, Journal of the International AIDS Society, Open AIDS Journal, HIV clinical trials journal, Journal of clinical research in HIV AIDS and prevention, Risk Behaviours of HIV/AIDS Journals, HIV/AIDS journals, Journal on HIV, HIV Journals, Journal of AIDS, AIDS and behavior journal, AIDS Patient Care and STDs, AIDS journal.

Advances in HIV Treatment

Antiretroviral therapy has revolutionized HIV treatment in the past few decades. And newer improvements such as one-pill-a-day drugs are making life with HIV person more easier and safer. ART works by combining drugs that attack the virus in different possible ways. ART doesn't cure HIV still it stops it from reproducing itself and spreading it across. The goal of treatment is to get the viral load so low that tests can't even detect the virus anymore.

Related Journals of Advances in HIV Treatment

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, Journal of the International Association of Physicians in AIDS Care, AIDS clinical review, HIV/AIDS policy law review / Canadian HIV/AIDS Legal Network and Journal of HIV/AIDS Prevention in Children and Youth, Journal of acquired immune deficiency syndrome, Advances in HIV Treatment, International HIV journal, AIDS Education and Prevention, International Journal of STD & AIDS, HIV/AIDS - Research and Palliative Care, HIV Medicine, Journal of AIDS and HIV research, AIDS research and treatment, AIDS Care, Antiretroviral Treatment Journals, Journal of the International AIDS Society, Open AIDS Journal, HIV clinical trials journal, Journal of clinical research in HIV AIDS and prevention, Risk Behaviours of HIV/AIDS Journals

Innovative HIV drugs

Currently, biopharmaceutical companies are concentrating on improving treatment regimens, more effective therapies and preventive vaccines that are either in clinical trials or awaiting review by the Food and Drug Administration (FDA) are in progress

• A first-in-class medicine intended to prevent HIV from breaking through the cell membrane.

• A cell therapy that modifies a patient’s own cells in an attempt to make them resistant to HIV.

• A therapeutic vaccine designed to induce responses from T cells that play a role in immune protection against viral infections

Related Journals of Innovative HIV drugs

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, Open AIDS Journal, AIDS analysis Africa, HIV/AIDS - Research and Palliative Care and Journal of AIDS and Clinical Research, HIV/AIDS - Research and Palliative Care, HIV Medicine, Journal of AIDS and HIV research, AIDS research and treatment, AIDS Care, Antiretroviral Treatment Journals, Journal of the International AIDS Society, Open AIDS Journal, HIV clinical trials journal, Journal of clinical research in HIV AIDS and prevention, Risk Behaviours of HIV/AIDS Journals, HIV/AIDS journals, Journal on HIV.

Advances in HIV Medications

Over the past years, HIV/AIDS has gone from a death sentence to a chronic, manageable disease, All thanks to large part to advances in biopharmaceutical research and development. The 44 medicines and vaccines in the development pipeline include 25 antivirals, 16 vaccines and three cell/gene therapies. However, many multiple medical advancements have taken place since 1981, when the CDC identified the first five cases of HIV/AIDS. Since anti-retroviral treatments (ART) were approved in 1995, HIV/AIDS-related deaths in the United States have dropped

Related Journals of Advances in HIV Medications

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, Pediatric AIDS and HIV Infection, AIDS alert, AIDS treatment news and  AIDS clinical review, Advances in HIV Treatment, International HIV journal, AIDS Education and Prevention, International Journal of STD & AIDS, HIV/AIDS - Research and Palliative Care, HIV Medicine, Journal of AIDS and HIV research, AIDS research and treatment, AIDS Care, Antiretroviral Treatment Journals, Journal of the International AIDS Society, Open AIDS Journal, HIV clinical trials journal, Journal of clinical research in HIV AIDS and prevention, Risk Behaviours of HIV/AIDS Journals, HIV/AIDS journals.

Advanced HIV Infection Preventive Measures

• Focusing on science-based HIV prevention efforts by supporting and expanding targeted use of high-impact HIV prevention approaches.

• Making better investments by intensifying HIV prevention in the communities where HIV is most heavily concentrated.

• Increasing access to HIV screening and medical care, including through

• Boosting federal investments for AIDS Drug Assistance Programs (ADAPs) to expand access to life-saving medications, and

• Implementing the Affordable Care Act, which will increase health coverage for thousands of Americans living with HIV?

Related Journals of Advanced HIV Infection Preventive Measures

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, Aidscaptions, AIDS policy & law, HIV and AIDS Review and Journal of the International Association of Providers of AIDS Care, HIV/AIDS - Research and Palliative Care, HIV Medicine, Journal of AIDS and HIV research, AIDS research and treatment, AIDS Care, Antiretroviral Treatment Journals, Journal of the International AIDS Society, Open AIDS Journal, HIV clinical trials journal, Journal of clinical research in HIV AIDS and prevention, Risk Behaviours of HIV/AIDS Journals, HIV/AIDS journals.

Highly Active Antiretroviral Therapy

Antiretroviral therapy (ART) is treatment designed for people infected with human immunodeficiency virus (HIV) using anti-HIV drugs. The treatment consists of a combination of at least three drugs (often called “highly active antiretroviral therapy” or HAART) that suppress HIV replication. Three drugs are used in order to reduce the survival of the virus developing resistance. ART has the potential both to reduce mortality and morbidity rates among HIV-infected people, and to improving their quality of life. A combination of three or more antiretroviral medicines is more effective than using just one medicine to treat HIV.The use of three or more antiretroviral medicines—sometimes referred to as an anti-HIV "cocktail"—is currently the standard treatment for HIV infection.

Related Journals of  Highly Active Antiretroviral Therapy

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, AIDS action, Harvard AIDS review,  AIDS/STD health promotion exchange and Current HIV/AIDS Reports, AIDS, Journal of acquired immune deficiency syndrome, Advances in HIV Treatment, International HIV journal, AIDS Education and Prevention, International Journal of STD & AIDS, HIV/AIDS - Research and Palliative Care, HIV Medicine, Journal of AIDS and HIV research, AIDS research and treatment, AIDS Care, Antiretroviral Treatment Journals, Journal of the International AIDS Society, Open AIDS Journal, HIV clinical trials journal, Journal of clinical research in HIV AIDS and prevention, Risk Behaviours of HIV/AIDS Journals.

Risk Analysis: HIV

The HIV/AIDS risk analysis is a process of gathering all relevant data about the organization and its staff members, to be able to investigate to what extent the organization is at risk regarding HIV/AIDS. A risk analysis focuses on identifying the characteristics of HIV and AIDS; how it affects the organization and staff; the degree of vulnerability; and the capacity of the organization to deal with HIV/AIDS. By doing a risk analysis, organizations can identify their risks towards HIV/AIDS and plan a strategy on overcoming these risks mainly by including those issues in the HIV and AIDS workplace policy development and implementation. HIV/AIDS risk analysis could be conducted at organizational level by assessing three variables of disaster risks which are hazard, vulnerability and capacity.

Related Journals of Risk Analysis: HIV

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, AIDS and Behavior, AIDS Patient Care and STDs, Current Opinion in HIV and AIDS and AIDS Research and Therapy, HIV/AIDS - Research and Palliative Care, HIV Medicine, Journal of AIDS and HIV research, AIDS research and treatment, AIDS Care, Antiretroviral Treatment Journals, Journal of the International AIDS Society, Open AIDS Journal, HIV clinical trials journal, Journal of clinical research in HIV AIDS and prevention, Risk Behaviours of HIV/AIDS Journals, HIV/AIDS journals.

Antiretroviral Treatment

Antiretroviral treatment are medications that treat HIV. The drugs do not kill or cure the virus. However, when taken in combination they can prevent the growth of the virus. When the virus is slowed down, so is HIV disease. Antiretroviral drugs are referred to as ARV. Combination ARV therapy (cART) is referred to as highly active ART (HAART). Each type, or “class”, of ARV drugs attacks HIV in a different way. The first class of anti-HIV drugs was the nucleoside reverse transcriptase inhibitors (also called NRTIs or “nukes”.) These drugs block step 4, where the HIV genetic material is used to create DNA from RNA.

Related Journals of Antiretroviral Treatment

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, AIDS Research and Therapy, AIDS Research and Treatment, AIDS clinical care and Journal of Neuro-AIDS, HIV/AIDS - Research and Palliative Care, HIV Medicine, Journal of AIDS and HIV research, AIDS research and treatment, AIDS Care, Antiretroviral Treatment Journals, Journal of the International AIDS Society, Open AIDS Journal, HIV clinical trials journal, Journal of clinical research in HIV AIDS and prevention, Risk Behaviours of HIV/AIDS Journals, HIV/AIDS journals, Journal on HIV, HIV Journals, Journal of AIDS, AIDS and behavior journal, AIDS Patient Care and STDs, AIDS journal.

HIV Super Infection

HIV-1 super infection in humans have been reported since 2002. Super infection is defined as the reinfection of an individual who already has an established infection with a heterologous HIV strain. Controversy exists surrounding superinfection, because it has implications concerning our understanding of worldwide HIV diversity, individual immunity and disease progression, and vaccine development. Here, we review the current understanding of HIV superinfection. The initial published reports involved individuals who were reinfected with a virus that belonged to a clade different from that of the initial infecting virus immune responses to the initial infection might be less likely to be protective against such a divergent superinfecting virus. Subsequently, however, reinfection with a virus that belonged to the same clade as the initial infecting virus (intraclade superinfection) started to be reported.

Related Journals of HIV Super Infection

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, AIDS Research and Therapy, AIDS Research and Treatment, AIDS clinical review, AIDS analysis Africa and Journal of AIDS and Clinical Research, Journal of acquired immune deficiency syndrome, Advances in HIV Treatment, International HIV journal, AIDS Education and Prevention, International Journal of STD & AIDS, HIV/AIDS - Research and Palliative Care, HIV Medicine, Journal of AIDS and HIV research, AIDS research and treatment, AIDS Care, Antiretroviral Treatment Journals, Journal of the International AIDS Society, Open AIDS Journal, HIV clinical trials journal, Journal of clinical research in HIV AIDS and prevention, Risk Behaviours of HIV/AIDS Journals.

Risk Behaviours of HIV/AIDS

In the United States, HIV is spread mainly through anal or vaginal sex or by sharing drug-use equipment with an infected person. Substance use can contribute to these risks indirectly because alcohol and other drugs can lower people’s inhibitions and make them less likely to use condoms. This section provides information on the various risk behaviours and what you can do to lower your risk.

• You have an increased risk for getting HIV if you:

• Are a man who has sex with other men.

• Have multiple sex partners, especially partners who inject drugs.

• Inject drugs or steroids, especially if you share needles, syringes, cookers, or other equipment used to inject drugs.

• Have high-risk partner(s) (a man or woman who has multiple sex partners or injects drugs, or a man who has sex with men).

• Have or have recently had a sexually transmitted infection, such as syphilis or genital herpes.

• Having sex with a person who has any of these behaviours also puts you at the same risk for becoming infected with other sexually transmitted infections

Related Journals of Risk Behaviours of HIV/AIDS

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, AIDS Research and Therapy, Journal of the International AIDS Society, African Journal of AIDS Research, AIDS and Public Policy Journal and AIDS Research and Treatment, HIV/AIDS - Research and Palliative Care, HIV Medicine, Journal of AIDS and HIV research, AIDS research and treatment, AIDS Care, Antiretroviral Treatment Journals, Journal of the International AIDS Society, ournal of AIDS, AIDS and behavior journal, AIDS Patient Care and STDs, AIDS journal.

Drug Resistance of HIV

The ability of HIV to mutate and reproduce itself in the presence of antiretroviral drugs is called HIV drug resistance (HIVDR). The consequences of HIVDR include treatment failure, need to start more costly second- and third- line treatments, increased health costs associated with these, spread of drug resistant HIV, and need to develop new anti-HIV drugs. WHO, and its partner organizations and experts of HIV ResNet group have developed a Global strategy for the surveillance and monitoring of HIV drug resistance. The strategy generates data on the emergence and transmission of HIVDR and equips countries with information to select first and second line antiretroviral therapy regimens.

Related Journals of Drug Resistance of HIV

Journal of Antivirals & Antiretrovirals, Journal of Infectious Diseases & Therapy, Virology & Mycology, Current HIV/AIDS Reports, AIDS Reader, AIDS Research and Therapy and Journal of the International AIDS Society, HIV/AIDS - Research and Palliative Care, HIV Medicine, Journal of AIDS and HIV research, AIDS research and treatment, AIDS Care, Antiretroviral Treatment Journals, Journal of the International AIDS Society, Open AIDS Journal, HIV clinical trials journal, Journal of clinical research in HIV AIDS and prevention, Risk Behaviours of HIV/AIDS Journals, HIV/AIDS journals.

*2015 Journal Impact Factor was established by dividing the number of articles published in 2013 and 2014 with the number of times they are cited in 2015 based on Google search and the Scholar Citation Index database. If 'X' is the total number of articles published in 2013 and 2014, and 'Y' is the number of times these articles were cited in indexed journals during 2015 then, impact factor = Y/X
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version